Oxycodone

U.S. teen drug and alcohol use remains low post-pandemic, according to NIDA's Monitoring the Future survey. Alcohol, vaping, cannabis, and illicit drug use among 8th, 10th, and 12th graders either declined or remained stable. The trend marks the lowest rates of substance use in decades.

Substance use among adolescents remained low in 2024, continuing a trend since the COVID-19 pandemic. The Monitoring the Future Survey, funded by NIH, found stable or declining use of most drugs, with alcohol, nicotine vaping, and cannabis seeing the most reported use. Factors contributing to this trend are under investigation to inform future interventions.

The top 5 most-read news articles of 2024 on The American Journal of Managed Care® included FDA approvals, study results, and drug shortages. Highlights: 1) High white blood cell counts linked to long-term COPD exacerbations. 2) FDA approved the first over-the-counter continuous glucose monitor. 3) FDA approved an abuse-deterrent oxycodone for severe pain. 4) Updated colonoscopy guidelines released. 5) Five essential drugs facing shortages in the US.

Lehigh County Department of Drug & Alcohol launches Rise Above Opioids, a website offering resources for opioid addiction, in partnership with Valley Youth House. The platform provides educational materials, support services, and a resource directory for prevention and recovery.

Dr. Marty Makary, Trump's FDA nominee, questions conventional medical wisdom in his book 'Blind Spots,' advocating alternative treatments and criticizing medical establishment 'groupthink.' His potential leadership could shift FDA focus to food regulation, but his book's selective use of evidence raises concerns about undermining FDA's drug approval standards and public trust. Makary's contrarian views, often based on observational studies, contrast with FDA's traditional reliance on rigorous clinical trials.

Kenosha County Public Health offers harm reduction vending machines at three locations, providing Narcan, fentanyl test strips, and other items free of charge. Machines are available 24/7 at the WIC office and Sharing Center, and from 8 a.m. to 5 p.m. at the Job Center. The HOPE Council also offers a similar machine.

President-elect Trump's healthcare agency nominations, including Dr. Marty Makary for FDA and Dr. Dave Weldon for CDC, have stirred mixed reactions from industry insiders. The nominees advocate for radical transparency, action on chronic health crises, and skepticism around vaccine schedules, potentially leading to controversial Senate confirmation hearings in 2025. The appointments aim for radical transparency and addressing chronic diseases, but face challenges in distancing from debunked vaccine claims.

Trump nominates Dr. Marty Makary to lead FDA, focusing on drug safety and reducing bureaucracy. He aligns with anti-vaccine advocate Robert F. Kennedy Jr., nominated for HHS. Trump also selects former Rep. Dave Weldon for CDC and Fox News contributor Janette Nesheiwat as surgeon general, reflecting a shift in public health policy.

President-elect Trump nominates Dr. Marty Makary to lead FDA, focusing on reducing bureaucracy and restoring scientific standards. Makary, a Johns Hopkins professor, opposes vaccine mandates and has criticized overprescribing and drug company influence. Trump also selects Dr. Dave Weldon for CDC and Janette Nesheiwat for Surgeon General, reflecting a shift in public health leadership.

Trump nominates Dr. Marty Makary to lead FDA, vowing to fix the 'broken' U.S. health system. Makary, a Johns Hopkins professor, opposes vaccine mandates and supports cutting FDA bureaucracy. Trump also nominates Dr. Dave Weldon for CDC and Janette Nesheiwat for surgeon general.